Dramatic decline of serogroup C meningococcal disease in Catalonia (Spain) after a mass vaccination campaign with meningococcal C conjugated vaccine

Vaccine. 2003 Jan 30;21(7-8):729-33. doi: 10.1016/s0264-410x(02)00590-x.

Abstract

In the last quarter of the year 2000, the meningococcal C conjugated vaccine was incorporated into the routine vaccination schedule in Catalonia (at 2, 4 and 6 months). In addition a vaccination campaign was carried out in children <6 years of age, with a coverage of 96.2%. The effectiveness of the vaccination in this age group during 2001 and the first 28 weeks of 2002 was 100% (94.27-100%). A vaccination campaign has been carried out in 6-19-year olds during 2001 and 2002, with a coverage rate of 23.5% in the year 2001. In this age group a reduction in disease incidence was seen in the 2000-2001 season, but not in the following one.

MeSH terms

  • Adolescent
  • Adult
  • Child
  • Child, Preschool
  • Humans
  • Immunization Schedule
  • Infant
  • Mass Vaccination / statistics & numerical data*
  • Meningitis, Meningococcal / epidemiology*
  • Meningococcal Vaccines* / administration & dosage
  • Neisseria meningitidis, Serogroup C / immunology*
  • Public Health
  • Spain / epidemiology
  • Vaccines, Conjugate / administration & dosage

Substances

  • Meningococcal Vaccines
  • Vaccines, Conjugate
  • serogroup C meningococcal conjugate vaccine